UBS Maintains Buy on Moderna, Raises Price Target to $151
MODERNA -1.42%
MODERNA MRNA | 60.20 | -1.42% |
UBS analyst Eliana Merle maintains Moderna (NASDAQ:
MRNA) with a Buy and raises the price target from $143 to $151.
UBS Maintains Buy on Moderna, Raises Price Target to $151
MODERNA MRNA | 60.20 | -1.42% |